{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:21:59Z","timestamp":1787761319997,"version":"build-2784847793"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,9,15]],"date-time":"2017-09-15T00:00:00Z","timestamp":1505433600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s00198-017-4189-7","type":"journal-article","created":{"date-parts":[[2017,9,15]],"date-time":"2017-09-15T08:15:59Z","timestamp":1505463359000},"page":"3301-3314","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":179,"title":["Inflammatory diseases and bone fragility"],"prefix":"10.1007","volume":"28","author":[{"given":"K.","family":"Briot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Geusens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Em Bultink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. F.","family":"Lems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,15]]},"reference":[{"key":"4189_CR1","doi-asserted-by":"crossref","unstructured":"Geusens P, Goldring SR, Briot K, Roux C (2016) The role of the immune system in the development of osteoporosis and fracture risk. In: Lorenzo J (ed) Osteoimmunology: interactions of the immune and skeletal systems, 2nd edn. Elsevier, pp 187\u2013214","DOI":"10.1016\/B978-0-12-800571-2.00011-6"},{"key":"4189_CR2","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","volume":"289","author":"SL Tetelbaum","year":"2000","unstructured":"Tetelbaum SL (2000) Bone resorption by osteoclasts. Science 289:1504\u20131508","journal-title":"Science"},{"key":"4189_CR3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1359\/jbmr.2000.15.1.2","volume":"15","author":"LC Hofbauer","year":"2000","unstructured":"Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL (2000) The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15:2\u201312","journal-title":"J Bone Miner Res"},{"key":"4189_CR4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","volume":"402","author":"YY Kong","year":"1999","unstructured":"Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S et al (1999) Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoproteogerin ligand. Nature 402:304\u2013309","journal-title":"Nature"},{"key":"4189_CR5","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1182\/blood-2006-07-037994","volume":"109","author":"Y Li","year":"2007","unstructured":"Li Y, Toraldo G, Li A, Yang X, Zhang H, Qian WP et al (2007) B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood 109:3839\u20133849","journal-title":"Blood"},{"key":"4189_CR6","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI11176","volume":"106","author":"J Lam","year":"2000","unstructured":"Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL (2000) TNF\u03b1 induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106:1481\u20131488","journal-title":"J Clin Invest"},{"key":"4189_CR7","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/art.24781","volume":"60","author":"R Axmann","year":"2009","unstructured":"Axmann R, B\u00f6hm C, Kr\u00f6nke G, Zwerina, Smolen J, Schett G (2009) Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo. Arthritis Rheum 60:2747\u20132756","journal-title":"Arthritis Rheum"},{"key":"4189_CR8","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/jbmr.5650081003","volume":"8","author":"EM Greenfield","year":"1993","unstructured":"Greenfield EM, Gornik SA, Horowitz MC, Donahue HJ, Shaw SM (1993) Regulation of cytokine expression in osteoblasts by parathyroid hormone: rapid stimulation of interleukin-6 and leukemia inhibitory factor mRNA. J Bone Miner Res 8:1163\u20131171","journal-title":"J Bone Miner Res"},{"key":"4189_CR9","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar2936","volume":"12","author":"IE Adamopoulos","year":"2010","unstructured":"Adamopoulos IE, Chao CC, Geissler R, Laface D, Blumenschein W, Iwakura Y et al (2010) Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors. Arthritis Res Ther 12:R29","journal-title":"Arthritis Res Ther"},{"key":"4189_CR10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fimmu.2016.00057","volume":"7","author":"R Pacifici","year":"2016","unstructured":"Pacifici R (2016) The role of IL-17 and TH17 cells in the bone catabolic activity of PTH. Front Immunol 7:57","journal-title":"Front Immunol"},{"key":"4189_CR11","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1002\/art.23138","volume":"56","author":"MM Zaiss","year":"2007","unstructured":"Zaiss MM, Axmann R, Zwerina J, Polzer K, G\u00fcckel E, Skapenko A, Schulze-Koops H, Horwood N, Cope A, Schett G (2007) Treg cells suppress ostoclast formation. A new link between the immune system and bone. Arthritis Rheum 56:4104\u20134112","journal-title":"Arthritis Rheum"},{"key":"4189_CR12","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1136\/ard.2007.080713","volume":"67","author":"R Axmann","year":"2008","unstructured":"Axmann R, Herman S, Zaiss M, Franz S, Polzer K, Zwerina J, Hermann M, Smolen J, Schett G (2008) CTLA-4 directly inhibits osteoclast formation. Ann Rheum Dis 67:1603\u20131609","journal-title":"Ann Rheum Dis"},{"key":"4189_CR13","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI60975","volume":"122","author":"U Harre","year":"2012","unstructured":"Harre U, Georgess D, Bang H, Bozec A, Axamann R, Ossipova E et al (2012) Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest 122:1791\u20131802","journal-title":"J Clin Invest"},{"key":"4189_CR14","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/annrheumdis-2012-202958","volume":"73","author":"A Kleyer","year":"2014","unstructured":"Kleyer A, Finzel S, Rech J, Manger B, Krieter M, Faustini F et al (2014) Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies. Ann Rheum Dis 73:854\u2013860","journal-title":"Ann Rheum Dis"},{"key":"4189_CR15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/art.30081","volume":"63","author":"J Sokolove","year":"2011","unstructured":"Sokolove J, Zhao X, Chandra PE, Robinson WH (2011) Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fc\u03b3 receptor. Arthritis Rheum 63:53\u201362","journal-title":"Arthritis Rheum"},{"key":"4189_CR16","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/annrheumdis-2015-208093","volume":"75","author":"A Krishnamurthy","year":"2016","unstructured":"Krishnamurthy A, Joshua V, Haj Hensvold A, Jin T, Sun M, Vivar N, Ytterberg AJ et al (2016) Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss. Ann Rheum Dis 75:721\u2013729","journal-title":"Ann Rheum Dis"},{"key":"4189_CR17","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1002\/1521-4141(200107)31:7<2179::AID-IMMU2179>3.0.CO;2-X","volume":"31","author":"Y Choi","year":"2001","unstructured":"Choi Y, Mi Woo K, Ko SH, Lee YJ, Park SJ, Kim HM et al (2001) Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8+ T cells. Eur J Immunol 31:2179\u20132188","journal-title":"Eur J Immunol"},{"key":"4189_CR18","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2004-01-0041","volume":"104","author":"A Rivollier","year":"2004","unstructured":"Rivollier A, Mazzorana M, Tebib J, Piperno M, Aitsiselmi T, Rabourdin-Combe C et al (2004) Immature dentritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment. Blood 104:4029\u20134037","journal-title":"Blood"},{"key":"4189_CR19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1182\/blood-2009-11-255026","volume":"116","author":"L Haiyan","year":"2010","unstructured":"Haiyan L, Hong S, Qian J, Zheng Y, Yang J, Yi Q (2010) Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cells. Blood 116:210\u2013217","journal-title":"Blood"},{"key":"4189_CR20","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1002\/art.23943","volume":"58","author":"S Herman","year":"2008","unstructured":"Herman S, Mueller R, Kronke G, Zwerina J, Redlich K, Hueber A, Gelse H, Neumann E, Mueller-Ladner U, Schett G (2008) OSCAR, a key co-stimulation molecule for osteoclasts, is induced in patients with rheumatoid arthritis. Arthritis Rheum 58:3041\u20133050","journal-title":"Arthritis Rheum"},{"key":"4189_CR21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/art.21537","volume":"54","author":"PKK Wong","year":"2006","unstructured":"Wong PKK, Quin JMW, Sims NA, van Nieuwenhuijze A, Campbell IK, Wicks IP (2006) Interleudin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced ostoclastogenesis. Arthritis Rheum 54:158\u2013168","journal-title":"Arthritis Rheum"},{"key":"4189_CR22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nm.1945","volume":"15","author":"NB Binder","year":"2009","unstructured":"Binder NB, Niederreiter B, Hoffmann O, Stange R, Pap T, Stulnig TM et al (2009) Estrogen-dependent and C-C chemokine receptor-2 dependent pathways determine osteoclast behavior in osteoporosis. Nat Med 15:417\u2013424","journal-title":"Nat Med"},{"key":"4189_CR23","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1359\/jbmr.070207","volume":"22","author":"N Charactcharoenwitthaya","year":"2007","unstructured":"Charactcharoenwitthaya N, Khosla S, Atkinson EJ, McCready LK, Riggs BL (2007) Effect of blockade of TNF-\u03b1 and interleukin-1 action on bone resorption in early postmenopausal women. J Bone Miner Res 22:724\u2013729","journal-title":"J Bone Miner Res"},{"key":"4189_CR24","doi-asserted-by":"crossref","unstructured":"Bedi B, Li JY, Tawfeek H, Baek KH, Adams J, Vangara SS et al (2012) Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTH. Proc Natl Acad Sci U S A 109:E725\u2013E733","DOI":"10.1073\/pnas.1120735109"},{"key":"4189_CR25","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1074\/jbc.M106339200","volume":"277","author":"L Gilbert","year":"2002","unstructured":"Gilbert L, He X, Farmer P, Rubin J, Drissi H, van Wijnen AJ et al (2002) Expression of the osteoblast differentiation factor RUNX2 (Cbfa1\/AML3\/Pebp2aA) is inhibited by tumor necrosis factor-\u03b1. J Biol Chem 277:2695\u20132701","journal-title":"J Biol Chem"},{"key":"4189_CR26","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1136\/ard.2010.132852","volume":"69","author":"GR Heiland","year":"2010","unstructured":"Heiland GR, Zwerina K, Baum W, Kireva T, Distler JH, Grisanti M et al (2010) Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression. Ann Rheum Dis 69:2152\u20132159","journal-title":"Ann Rheum Dis"},{"key":"4189_CR27","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1136\/annrheumdis-2013-203345","volume":"72","author":"XX Chen","year":"2013","unstructured":"Chen XX, Baum W, Dwyer D, Stock M, Schwabe K, Ke HZ et al (2013) Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis. Ann Rheum Dis 72:1732\u20131736","journal-title":"Ann Rheum Dis"},{"key":"4189_CR28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/ard.2008.091611","volume":"68","author":"CA Wijbrandts","year":"2009","unstructured":"Wijbrandts CA, Klaasen R, Dijkgraaf MGW, Gerlag DM, van Eck-Smit BLF, Tak PP (2009) Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss. Ann Rheum Dis 68:373\u2013376.57","journal-title":"Ann Rheum Dis"},{"key":"4189_CR29","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/ard.2007.073817","volume":"67","author":"M G\u00fcler-Y\u00fcksel","year":"2008","unstructured":"G\u00fcler-Y\u00fcksel M, Bijsterbosch J, Goekoop-Ruiterman YP et al (2008) Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis. Ann Rheum Dis 67:823\u2013828","journal-title":"Ann Rheum Dis"},{"key":"4189_CR30","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/ard.2007.086348","volume":"68","author":"M G\u00fcler-Y\u00fcksel","year":"2009","unstructured":"G\u00fcler-Y\u00fcksel M, Allaart CF, Goekoop-Ruiterman YP et al (2009) Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis. Ann Rheum Dis 68:330\u2013336","journal-title":"Ann Rheum Dis"},{"key":"4189_CR31","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1136\/ard.2009.121657","volume":"69","author":"G Schett","year":"2010","unstructured":"Schett G, Firestein GS (2010) Mr Outside and Mr Inside: classic and alternative views on the pathogenesis of rheumatoid arthritis. Ann Rheum Dis 69:787\u2013789","journal-title":"Ann Rheum Dis"},{"key":"4189_CR32","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/ard.2005.043869","volume":"65","author":"G Haugeberg","year":"2006","unstructured":"Haugeberg G, Green MJ, Quinn MA et al (2006) Hand bone loss in early undifferentiated arthritis: evaluating bone mineral density loss before the development of rheumatoid arthritis. Ann Rheum Dis 65:736\u2013740","journal-title":"Ann Rheum Dis"},{"key":"4189_CR33","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1002\/art.22117","volume":"54","author":"TP Staa van","year":"2006","unstructured":"van Staa TP, Geusens P, Bijlsma JW et al (2006) Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 54:3104\u20133112","journal-title":"Arthritis Rheum"},{"key":"4189_CR34","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.3899\/jrheum.100363","volume":"37","author":"RJ Weiss","year":"2010","unstructured":"Weiss RJ, Wick MC, Ackermann PW, Montgomery SM (2010) Increased fracture risk in patients with rheumatic disorders and other inflammatory diseases\u2014a case-control study with 53,108 patients with fracture. J Rheumatol 37:2247\u20132250","journal-title":"J Rheumatol"},{"key":"4189_CR35","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3899\/jrheum.121493","volume":"40","author":"S Amin","year":"2013","unstructured":"Amin S, Gabriel SE, Achenbach SJ, Atkinson EJ, Melton LJ 3rd (2013) Are young women and men with rheumatoid arthritis at risk for fragility fractures? A population-based study. J Rheumatol 40:1669\u20131676","journal-title":"J Rheumatol"},{"key":"4189_CR36","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00198-014-2911-2","volume":"26","author":"K Ochi","year":"2015","unstructured":"Ochi K, Inoue E, Furuya T, Ikari K, Toyama Y, Taniguchi A, Yamanaka H, Momohara S (2015) Ten-year incidences of self-reported non-vertebral fractures in Japanese patients with rheumatoid arthritis: discrepancy between disease activity control and the incidence of non-vertebral fracture. Osteoporos Int 26:961\u2013968","journal-title":"Osteoporos Int"},{"key":"4189_CR37","doi-asserted-by":"crossref","unstructured":"Klop C, de Vries F, Bijlsma JW, Leufkens HG, Welsing PM (2016) Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density. Ann Rheum Dis 75:2095\u20132100","DOI":"10.1136\/annrheumdis-2015-208958"},{"key":"4189_CR38","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s00198-012-1958-1","volume":"23","author":"S Lekamwasam","year":"2012","unstructured":"Lekamwasam S, Adachi JD, Agnusdei D et al (2012) A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int 23:2257\u20132276","journal-title":"Osteoporos Int"},{"key":"4189_CR39","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1002\/art.24879","volume":"60","author":"KG Saag","year":"2009","unstructured":"Saag KG, Zanchetta JR, Devogelaer JP, Adler RA, Eastell R, See K, Krege JH, Krohn K, Warner MR (2009) Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial. Arthritis Rheum 60:3346\u20133355","journal-title":"Arthritis Rheum"},{"key":"4189_CR40","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1007\/s00198-013-2334-5","volume":"24","author":"M Vis","year":"2012","unstructured":"Vis M, G\u00fcler-Y\u00fcksel M, Lems WF (2012) Can bone loss be prevented in RA? Osteoporos Int 24:2541\u20132553","journal-title":"Osteoporos Int"},{"key":"4189_CR41","doi-asserted-by":"publisher","unstructured":"Manara M, Sinigaglia L (2015) Bone and TNF in rheumatoid arthritis: clinical implications. RMD Open 1(Suppl 1):e000065. doi: 10.1136\/rmdopen-2015-000065","DOI":"10.1136\/rmdopen-2015-000065"},{"key":"4189_CR42","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s10067-012-2018-0","volume":"31","author":"MAC Weijden Van der","year":"2012","unstructured":"Van der Weijden MAC, Claushuis TAM, Nazari T, Lems WF, Dijkmans BAC, Van der Horst-Bruinsma EI (2012) High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review. Clin Rheumatol 31:1529\u20131535","journal-title":"Clin Rheumatol"},{"key":"4189_CR43","first-page":"2205","volume":"26","author":"A Maghraoui El","year":"1999","unstructured":"El Maghraoui A, Borderie D, Cherruau B, Edouard R, Dougados M, Roux C (1999) Osteoporosis, body composition, and bone turnover in ankylosing spondylitis. J Rheumatol 26:2205\u20132209","journal-title":"J Rheumatol"},{"key":"4189_CR44","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s001980170084","volume":"12","author":"JF Maillefert","year":"2001","unstructured":"Maillefert JF, Aho S, El Maghraoui A, Dougados M, Roux C (2001) Changes in bone density in patients with ankylosing spondylitis: a 2 year follow-up study. Osteoporos Int 12:605\u2013609","journal-title":"Osteoporos Int"},{"key":"4189_CR45","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/1529-0131(199911)42:11<2319::AID-ANR9>3.0.CO;2-G","volume":"42","author":"J Gratacos","year":"1999","unstructured":"Gratacos J, Collado A, Pons F, Osaba M, Sammarti R, Roqu\u00e9 M et al (1999) Significant loss of bone mass in patients with early, active ankylosing spondylitis. A follow-up study. Arthritis Rheum 42:2319\u20132324","journal-title":"Arthritis Rheum"},{"key":"4189_CR46","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1136\/annrheumdis-2012-201845","volume":"72","author":"K Briot","year":"2013","unstructured":"Briot K, Durnez A, Paternotte S, Miceli-Richard C, Dougados M, Roux C (2013) Bone oedema on MRI is highly associated with low bone mineral density in patients with early inflammatory back pain: results from the DESIR cohort. Ann Rheum Dis 72:1914\u20131919","journal-title":"Ann Rheum Dis"},{"key":"4189_CR47","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/rheumatology\/ket385","volume":"53","author":"G Akg\u00f6l","year":"2014","unstructured":"Akg\u00f6l G, Kamanli A, Ozgocmen S (2014) Evidence for inflammation-induced bone loss in non-radiographic axial spondyloarthritis. Rheumatolojy (Oxford) 53:497\u2013501","journal-title":"Rheumatolojy (Oxford)"},{"key":"4189_CR48","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s00198-015-3044-y","volume":"26","author":"M Forien","year":"2015","unstructured":"Forien M, Molto A, Etcheto A et al (2015) Bone mineral density in patients with symptoms suggestive of spondyloarthritis. Osteoporos Int 26:1647\u20131653","journal-title":"Osteoporos Int"},{"key":"4189_CR49","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1136\/ard.2008.100503","volume":"68","author":"D Vosse","year":"2009","unstructured":"Vosse D, Landew\u00e9 R, van der Heijde D, van der Linden S, van Staa TP, Geusens P (2009) Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case-control study. Ann Rheum Dis 68:1839\u20131842","journal-title":"Ann Rheum Dis"},{"key":"4189_CR50","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s13075-015-0809-9","volume":"17","author":"P Geusens","year":"2015","unstructured":"Geusens P, De Winter L, Quaden D, Vanhoof J, Vosse D, van den Bergh J, Somers V (2015) The prevalence of vertebral fractures in spondyloarthritis: relation to disease characteristics, bone mineral density, syndesmophytes and history of back pain and trauma. Arthritis Res Ther 17:294","journal-title":"Arthritis Res Ther"},{"key":"4189_CR51","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00296-008-0567-y","volume":"28","author":"D Stupphann","year":"2008","unstructured":"Stupphann D, Ranner M, Krenbeck D et al (2008) Intracellular and surface RANK L are differentially regulated in patients with ankylosing spondylitis. Rheumatol Int 28:987\u2013993","journal-title":"Rheumatol Int"},{"key":"4189_CR52","doi-asserted-by":"crossref","unstructured":"Briot K, Garnero P, Le Henanff A, Dougados M, Roux C (2005) Body weight, body composition and bone turnover changes in patients with spondyloarthropathy receiving anti-TNF alpha treatment. Ann Rheum Dis 64:1137\u20131140","DOI":"10.1136\/ard.2004.028670"},{"key":"4189_CR53","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00198-010-1338-7","volume":"22","author":"S Arends","year":"2011","unstructured":"Arends S, Spoorenberg A, Bruyn GAW et al (2011) The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis. Osteoporos Int 22:1431\u20131439","journal-title":"Osteoporos Int"},{"key":"4189_CR54","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","volume":"18","author":"JP Sherlock","year":"2012","unstructured":"Sherlock JP, Joyce-Shaikh B, Turner SP et al (2012) IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+CD3+CD4\u2212CD8\u2212entheseal resident T cells. Nat Med 18:1069\u20131076","journal-title":"Nat Med"},{"key":"4189_CR55","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz-Ortego J, Vestergaard P, Rubio JB, Wordsworth P, Judge A, Javaid MK, Arden NK, Cooper C, D\u00edez-P\u00e9rez A, Prieto-Alhambra D (2014) Ankylosing spondylitis is associated with an increased risk of vertebral and nonvertebral clinical fractures: a population-based cohort study. J Bone Miner Res 29(8):1770\u20131776","DOI":"10.1002\/jbmr.2217"},{"issue":"1","key":"4189_CR56","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00198-014-2939-3","volume":"26","author":"D Prieto-Alhambra","year":"2015","unstructured":"Prieto-Alhambra D, Mu\u00f1oz-Ortego J, De Vries F, Vosse D, Arden NK, Bowness P, Cooper C, Diez-Perez A, Vestergaard P (2015) Ankylosing spondylitis confers substantially increased risk of clinical spine fractures: a nationwide case-control study. Osteoporos Int 26(1):85\u201391","journal-title":"Osteoporos Int"},{"key":"4189_CR57","first-page":"855","volume":"35","author":"K Briot","year":"2008","unstructured":"Briot K, Gossec L, Kolta S, Dougados M, Roux C (2008) Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment. J Rheumatol 35:855\u2013861","journal-title":"J Rheumatol"},{"key":"4189_CR58","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3899\/jrheum.121417","volume":"40","author":"A Durnez","year":"2013","unstructured":"Durnez A, Paternotte S, Fechtenbaum J, Landew\u00e9 RB, Dougados M, Roux C, Briot K (2013) Increase in bone density in patients with spondyloarthritis during anti-tumor necrosis factor therapy: 6-year follow-up study. J Rheumatol 40:1712\u20131718","journal-title":"J Rheumatol"},{"key":"4189_CR59","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.semarthrit.2014.05.008","volume":"44","author":"NN Haroon","year":"2014","unstructured":"Haroon NN, Sriganthan J, Al Ghanim N et al (2014) Effect of TNF-alpha inhibitor treatment on bone mineral density in patients with ankylosing spondylitis: a systematic review and meta-analysis. Semin Arthritis Rheum 44:155\u2013161","journal-title":"Semin Arthritis Rheum"},{"key":"4189_CR60","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/rheumatology\/kev332","volume":"55","author":"K Briot","year":"2016","unstructured":"Briot K, Etcheto A, Miceli-Richard C, Dougados M, Roux C (2016) Bone loss in patients with early inflammatory back pain suggestive of spondyloarthritis: results from the prospective DESIR cohort. Rheumatology (Oxford) 55:335\u2013422","journal-title":"Rheumatology (Oxford)"},{"key":"4189_CR61","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/acr.22751","volume":"68","author":"F Rees","year":"2015","unstructured":"Rees F, Doherty M, Grainge M, Lanyon P, Davenport G, Zhang W (2015) Burden of comorbidity in systemic lupus erythematosus in the UK, 1999-2012. Arthritis Care Res (Hoboken) 68:819\u2013827","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4189_CR62","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/acr.20568","volume":"64","author":"IEM Bultink","year":"2012","unstructured":"Bultink IEM (2012) Osteoporosis and fractures in systemic lupus erythematosus. Arthritis Care Res (Hoboken) 64:2\u20138","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4189_CR63","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/BOR.0000000000000290","volume":"28","author":"IEM Bultink","year":"2016","unstructured":"Bultink IEM, Lems WF (2016) Lupus and fractures. Curr Opin Rheumatol 28:426\u2013432","journal-title":"Curr Opin Rheumatol"},{"key":"4189_CR64","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00198-013-2587-z","volume":"25","author":"IE Bultink","year":"2014","unstructured":"Bultink IE, Harvey NC, Lalmohamed A, Cooper C, Lems WF, van Staa TP, de Vries F (2014) Elevated risk of clinical fractures and associated risk factors in patients with systemic lupus erythematosus versus matched controls: a population-based study in the United Kingdom. Osteoporos Int 25:1275\u20131283","journal-title":"Osteoporos Int"},{"key":"4189_CR65","doi-asserted-by":"crossref","first-page":"e000098","DOI":"10.1136\/lupus-2015-000098","volume":"3","author":"L Carli","year":"2016","unstructured":"Carli L, Tani C, Spera V, Vagelli R, Vagnani S, Mazzantini M, Di Munno O, Mosca M (2016) Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus. Lupus Sci Med 3:e000098","journal-title":"Lupus Sci Med"},{"key":"4189_CR66","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.3899\/jrheum.081337","volume":"36","author":"EK Li","year":"2009","unstructured":"Li EK, Tam LS, Griffith JF, Zhu TY, Li TK, Li M, Wong KC, Chan M, Lam CW, Chu FS, Wong KK, Leung PC, Kwok A (2009) High prevalence of asymptomatic vertebral fractures in Chinese women with systemic lupus erythematosus. J Rheumatol 36:1646\u20131652","journal-title":"J Rheumatol"},{"key":"4189_CR67","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10067-009-1105-3","volume":"28","author":"C Mendoza-Pinto","year":"2009","unstructured":"Mendoza-Pinto C, Garc\u00eda-Carrasco M, Sandoval-Cruz H, Mu\u00f1oz-Guarneros M, Esc\u00e1rcega RO, Jim\u00e9nez-Hern\u00e1ndez M, Munguia-Realpozo P, Sandoval-Cruz M, Delez\u00e9-Hinojosa M, L\u00f3pez-Colombo A, Cervera R (2009) Risk factors of vertebral fractures in women with systemic lupus erythematosus. Clin Rheumatol 28:579\u2013585","journal-title":"Clin Rheumatol"},{"key":"4189_CR68","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/art.1790080305","volume":"8","author":"M Petri","year":"1995","unstructured":"Petri M (1995) Musculoskeletal complications of systemic lupus erythematosus in the Hopkins Lupus Cohort: an update. Arthritis Care Res 8:137\u2013145","journal-title":"Arthritis Care Res"},{"key":"4189_CR69","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/art.21110","volume":"54","author":"IE Bultink","year":"2005","unstructured":"Bultink IE, Lems WF, Kostense PJ, Dijkmans BA, Voskuyl AE (2005) Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 54:2044\u20132050","journal-title":"Arthritis Rheum"},{"key":"4189_CR70","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s00198-012-2157-9","volume":"24","author":"J Jacobs","year":"2013","unstructured":"Jacobs J, Korswagen LA, Schilder AM, van Tuyl LH, Dijkmans BAC, Lems WF, Voskuyl AE, Bultink IEM (2013) Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus. Osteoporos Int 24:1827\u20131833","journal-title":"Osteoporos Int"},{"key":"4189_CR71","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1191\/0961203303lu412oa","volume":"12","author":"E Svenungsson","year":"2003","unstructured":"Svenungsson E, Fei GZ, Jensen-Urstad K, de Faire U, Hamsten A, Frostegard J (2003) TNF-alpha: a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease. Lupus 12:454\u2013461","journal-title":"Lupus"},{"key":"4189_CR72","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.20780","volume":"52","author":"J Frostegard","year":"2005","unstructured":"Frostegard J, Svenungsson E, Wu R, Gunnarsson I, Lundberg IE, Klareskog L, H\u00f6rkk\u00f6 S, Witztum JL (2005) Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Arthritis Rheum 52:192\u2013200","journal-title":"Arthritis Rheum"},{"key":"4189_CR73","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1474-9728.2004.00127.x","volume":"6","author":"EJ Moerman","year":"2004","unstructured":"Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B (2004) Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma\/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta\/BMP signaling pathways. Aging Cell 6:379\u2013389","journal-title":"Aging Cell"},{"key":"4189_CR74","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.3899\/jrheum.131190","volume":"41","author":"TY Zhu","year":"2014","unstructured":"Zhu TY, Griffith JF, Au SK, Tang XA, Kwok AW, Leung PC, Li EK, Tam LS (2014) Bone mineral density change in systemic lupus erytehmatosus: a 5-year followup study. J Rheumatol 41:1990\u20131997","journal-title":"J Rheumatol"},{"key":"4189_CR75","first-page":"2535","volume":"11","author":"AM Huisman","year":"2013","unstructured":"Huisman AM, White KP, Algra A, Harth M, Vieth R, Jacobs JW, Bijlsma JW, Bell DA (2013) Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol 11:2535\u20132539","journal-title":"J Rheumatol"},{"key":"4189_CR76","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1191\/0961203305lu2039oa","volume":"14","author":"CC Mok","year":"2005","unstructured":"Mok CC, Mak A, Ma KM (2005) Bone mineral density in postmenopausal Chinese patients with systemic lupus erythematosus. Lupus 14:106\u2013112","journal-title":"Lupus"},{"key":"4189_CR77","first-page":"0765","volume":"33","author":"J Jacobs","year":"2015","unstructured":"Jacobs J, Voskuyl AE, Korswagen LA, Theunissen R, Cohen Tervaert JW, Bultink IEM (2015) The association between FOK-I vitamin D receptor gene polymorphisms and bone mineral density in patients with systemic lupus erythematosus. Clin Exp Rheumatol 33:0765","journal-title":"Clin Exp Rheumatol"},{"key":"4189_CR78","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-133-10-200011210-00012","volume":"133","author":"CN Bernstein","year":"2000","unstructured":"Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN (2000) The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med 133:795\u2013799","journal-title":"Ann Intern Med"},{"key":"4189_CR79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/aje\/kwf007","volume":"156","author":"P Vestergaard","year":"2002","unstructured":"Vestergaard P, Mosekilde L (2002) Fracture risk in patients with celiac disease, Crohn\u2019s disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark. Am J Epidemiol 156:1\u201310","journal-title":"Am J Epidemiol"},{"key":"4189_CR80","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/gut.2003.026799","volume":"53","author":"T Card","year":"2004","unstructured":"Card T, West J, Hubbard R, Logan RF (2004) Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study. Gut 53:251\u2013255","journal-title":"Gut"},{"key":"4189_CR81","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ibd.20541","volume":"15","author":"WD Leslie","year":"2009","unstructured":"Leslie WD, Miller N, Rogala L, Bernstein CN (2009) Body mass and composition effect bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study. Inflamm Bowel Dis 15:39\u201346","journal-title":"Inflamm Bowel Dis"},{"key":"4189_CR82","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/ijcp.12526","volume":"69","author":"MS Tsai","year":"2015","unstructured":"Tsai MS, Lin CL, Tu YK, Lee PH, Kao CH (2015) Risks and predictors of osteoporosis in patients with inflammatory bowel diseases in an Asian population: a nationwide population-based cohort study. Int J Clin Pract 69:235\u2013241","journal-title":"Int J Clin Pract"},{"key":"4189_CR83","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00223-012-9650-1","volume":"91","author":"LE Targownik","year":"2012","unstructured":"Targownik LE, Leslie WD, Carr R, Clara I, Miller N, Rogala L, Graff LA, Walker JR, Bernstein CN (2012) Longitudinal change in bone mineral density in a population-based cohort of patients with inflammatory bowel disease. Calcif Tissue Int 91:356\u2013363","journal-title":"Calcif Tissue Int"},{"key":"4189_CR84","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S1074-7613(03)00326-1","volume":"19","author":"AJ Ashcroft","year":"2003","unstructured":"Ashcroft AJ, Cruickshank SM, Croucher PI, Perry MJ, Rollinson S, Lippitt JM, Child JA, Dunstan C, Felsburg PJ, Morgan GJ, Carding SR (2003) Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin. Immunity 19:849\u2013861","journal-title":"Immunity"},{"key":"4189_CR85","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/gut.2004.044370","volume":"54","author":"AR Moschen","year":"2005","unstructured":"Moschen AR, Kaser A, Enrich B, Ludwiczek O, Gabriel M, Obrist P, Wolf AM, Tilg H (2005) The RANKL\/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss. Gut 54:479\u2013487","journal-title":"Gut"},{"key":"4189_CR86","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0016-5085(94)90227-5","volume":"107","author":"S Ghosh","year":"1994","unstructured":"Ghosh S, Cowen S, Hannan WJ, Ferguson A (1994) Low bone mineral density in Crohn\u2019s disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 107:1031\u20131039","journal-title":"Gastroenterology"},{"key":"4189_CR87","unstructured":"Abitbol V, Roux C, Gillemant S, Valleur P, Hautefeuille P, Dougados M, Couturier D, Chaussade S (1998) Bone assessment in patients with ileal pouch-anal anastomosis for inflammatory bowel disease. Br J Surg:1551\u20131554"},{"key":"4189_CR88","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/gastro\/got030","volume":"1","author":"S Gupta","year":"2013","unstructured":"Gupta S, Shen B (2013) Bone loss in patients with the ileostomy and ileal pouch for inflammatory bowel disease. Gastroenterol Rep (Oxf) 1:159\u2013165","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"4189_CR89","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1111\/j.1572-0241.2003.07590.x","volume":"98","author":"CN Bernstein","year":"2003","unstructured":"Bernstein CN, Blanchard JF, Metge C, Yogendran M (2003) The association between corticosteroid use and development of fractures among IBD patients in a population-based database. Am J Gastroenterol 98:1797\u20131801","journal-title":"Am J Gastroenterol"},{"key":"4189_CR90","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1007\/s10620-014-3102-x","volume":"59","author":"BP Abraham","year":"2014","unstructured":"Abraham BP, Prasad P, Malaty HM (2014) Vitamin D deficiency and corticosteroid use are risk factors for low bone mineral density in inflammatory bowel disease patients. Dig Dis Sci 59:1878\u20131884","journal-title":"Dig Dis Sci"},{"key":"4189_CR91","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/BF02106094","volume":"5","author":"C Roux","year":"1995","unstructured":"Roux C, Abitbol V, Chaussade S, Kolta S, Guillemant S, Dougados M, Amor B, Couturier D (1995) Bone loss in patients with inflammatory bowel disease: a prospective study. Osteoporos Int 5:156\u2013160","journal-title":"Osteoporos Int"},{"key":"4189_CR92","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/j.1572-0241.2007.01753.x","volume":"103","author":"WD Leslie","year":"2008","unstructured":"Leslie WD, Miller N, Rogala L, Bernstein CN (2008) Vitamin D status and bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study. Am J Gastroenterol 103:1451\u20131459","journal-title":"Am J Gastroenterol"},{"key":"4189_CR93","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1053\/gast.2003.50106","volume":"124","author":"CN Bernstein","year":"2003","unstructured":"Bernstein CN, Leslie WD, Leboff MS (2003) AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology 124:795\u2013841","journal-title":"Gastroenterology"},{"key":"4189_CR94","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cgh.2013.08.024","volume":"12","author":"J Melek","year":"2014","unstructured":"Melek J, Sakuraba A (2014) Efficacy and safety of medical therapy for low bone mineral density in patients with inflammatory bowel disease: a meta-analysis and systematic review. Clin Gastroenterol Hepatol 12:32\u201344.e5","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"4189_CR95","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2036.2004.02152.x","volume":"20","author":"N Franchimont","year":"2004","unstructured":"Franchimont N, Putzeys V, Collette J, Vermeire S, Rutgeerts P, De Vos M, Van Gossum A, Franchimont D, Fiasse R, Pelckmans P, Malaise M, Belaiche J, Louis E (2004) Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease. Aliment Pharmacol Ther 20(6):607\u2013614","journal-title":"Aliment Pharmacol Ther"},{"key":"4189_CR96","doi-asserted-by":"crossref","unstructured":"Majumdar SR, Villa-Roel C, Lyons KJ, Rowe BH (2010) Prevalence and predictors of vertebral fracture in patients with chronic obstructive pulmonary disease. Respir Med 104:260\u2013266","DOI":"10.1016\/j.rmed.2009.09.013"},{"key":"4189_CR97","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1359\/jbmr.061202","volume":"22","author":"RA Harrison","year":"2007","unstructured":"Harrison RA, Siminoski K, Vetkanayagam D, Majumdar SR (2007) Osteoporosis-related kyphosis and impairments in pulmonary function: a systematic review. J Bone Miner Res 22:448\u2013557","journal-title":"J Bone Miner Res"},{"key":"4189_CR98","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.rmed.2009.02.014","volume":"103","author":"L Graat-Verboom","year":"2009","unstructured":"Graat-Verboom L, Spruit MA, van den Borne BE et al (2009) CIRO Network. Correlates of osteoporosis in chronic obstructive pulmonary disease: an underestimated systemic component. Respir Med 103:1143\u20131151","journal-title":"Respir Med"},{"key":"4189_CR99","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00198-008-0770-4","volume":"20","author":"R Nutti","year":"2009","unstructured":"Nutti R, Siviero P, Maggi S et al (2009) Vertebral fractures in patients with chronic obstructive pulmonary disease: the EOLO study. Osteoporos Int 20:989\u2013998","journal-title":"Osteoporos Int"},{"key":"4189_CR100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10654-007-9211-5","volume":"23","author":"C Luise De","year":"2008","unstructured":"De Luise C, Brimacombe M, Pedersen L, Sorensen HT (2008) Chronic obstructive pulmonary disease and mortality following hip fracture: a population-based cohort study. Eur J Epidemiol 23:115\u2013122","journal-title":"Eur J Epidemiol"},{"key":"4189_CR101","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1440-1843.2012.02265.x","volume":"18","author":"AG Mathioudakis","year":"2013","unstructured":"Mathioudakis AG, Amanetopoulou SG, Gialmanidis IP et al (2013) Impact of long-term treatement with low-dose inhaled corticosteroids on the bone mineral density of chronic obstructive pulmonary disease patients: aggravating or beneficial? Respirology 18:147\u2013153","journal-title":"Respirology"},{"key":"4189_CR102","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1465-9921-12-157","volume":"12","author":"P Bai","year":"2011","unstructured":"Bai P, Sun Y, Jin J, Hou J, Li R, Zhang Q, Wang Y (2011) Disturbance of the OPG\/RANK\/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis. Respir Res 12:157","journal-title":"Respir Res"},{"key":"4189_CR103","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3109\/15412555.2013.813928","volume":"10","author":"PF Zhang","year":"2013","unstructured":"Zhang PF, Pan L, Luo ZY, Zhao HJ, Cai SX (2013) Interrelationship of circulating matrix metalloproteinase-9, TNF-\u03b1, and OPG\/RANK\/RANKL systems in COPD patients with osteoporosis. COPD 10:650\u2013656","journal-title":"COPD"},{"key":"4189_CR104","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/jbmr.257","volume":"26","author":"L Graat-Verboom","year":"2011","unstructured":"Graat-Verboom L, van den Borne BEEM, Smeenk FWJM, Spruit MA, Wouters EFM (2011) Osteoporosis in COPD outpatients based on bone mineral density and vertebral fractures. J Bone Miner Res 26:561\u2013568","journal-title":"J Bone Miner Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-017-4189-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-017-4189-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-017-4189-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T10:39:09Z","timestamp":1570099149000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-017-4189-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,15]]},"references-count":104,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["4189"],"URL":"https:\/\/doi.org\/10.1007\/s00198-017-4189-7","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,15]]}}}